Not applicableStudy completedNCT04384848What this trial is testingThe EMPATHY Pilot StudyWho this might be right forLeukemia, Chronic MyeloidCancer Northwestern University 94
Testing effectiveness (Phase 2)Study completedNCT00285259What this trial is testingCytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)Who this might be right forAcute Lymphoblastic LeukemiaChronic Myelogenous LeukemiaAcute Myelogenous Leukemia+3 more Astellas Pharma Inc 112
Testing effectiveness (Phase 2)Study completedNCT00003396What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07819396What this trial is testingDepletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic SyndromeWho this might be right forAcute Biphenotypic LeukemiaAcute LeukemiaAcute Leukemia of Ambiguous Lineage+11 more Fred Hutchinson Cancer Center 52
Not applicableUnknownNCT01761890What this trial is testingFront-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With DasatinibWho this might be right forChronic Myeloid Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 147
Testing effectiveness (Phase 2)Study completedNCT00661180What this trial is testingOpen Label Phase II Study of BAY 43-9006 in Chronic Myelogenous Leukemia (CML) Patients Resistant to GleevecWho this might be right forChronic Myelogenous Leukemia Bayer 10
Not applicableStudy completedNCT03454503What this trial is testingEffectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in EgyptWho this might be right forPhiladelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase Hikma Pharmaceuticals LLC 173
Testing effectiveness (Phase 2)Active Not RecruitingNCT05007873What this trial is testingASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic PhaseWho this might be right forChronic Phase Chronic Myelogenous LeukemiaPhiladelphia Chromosome PositiveBCR-ABL1 Positive Chronic Myelogenous Leukemia+1 more M.D. Anderson Cancer Center 39
Testing effectiveness (Phase 2)Looking for participantsNCT06453902What this trial is testingTGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) PatientsWho this might be right forChronic Myeloid LeukemiaAccelerated Phase CML Shenzhen TargetRx Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00003913What this trial is testingUmbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic DiseaseWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Fred Hutchinson Cancer Center 390
Not applicableStudy completedNCT01490853What this trial is testingFollow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based TherapyWho this might be right forChronic Myeloid Leukemia Università degli Studi di Brescia 116
Not applicableStudy completedNCT03678454What this trial is testingIclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in BelgiumWho this might be right forChronic Myeloid LeukemiaCMLPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia+1 more Incyte Biosciences Benelux 80
Testing effectiveness (Phase 2)Study completedNCT00611351What this trial is testingBusulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+4 more University of Nebraska 5
Early research (Phase 1)Not Yet RecruitingNCT06672263What this trial is testingA Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive LeukemiaWho this might be right forChronic Myelogenous Leukemia Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 120
Large-scale testing (Phase 3)Study completedNCT00264160What this trial is testingEfficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate TherapyWho this might be right forLeukemia, Myeloid, Chronic Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT00048672What this trial is testingTherapy of Early Chronic Phase CML With GleevecWho this might be right forLeukemia, Myeloid, Chronic-Phase M.D. Anderson Cancer Center 50
Not applicableEnded earlyNCT01761695What this trial is testingChronic Myelod Leukemia Registry at Asan Medical CenterWho this might be right forLeukemia, Chronic MyeloidMyeloid Leukemia, Chronic, Accelerated PhaseMyeloid Leukemia, Chronic, Chronic Phase Asan Medical Center 100
Not applicableLooking for participantsNCT06082804What this trial is testingEvaluation of Advanced Practice Nurse's Management of Patients With Chronic Myeloid LeukemiaWho this might be right forChronic Myelogenous Leukemia - Chronic Phase Centre Hospitalier Henri Duffaut - Avignon 60
Large-scale testing (Phase 3)Study completedNCT00075478What this trial is testingTotal-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionAggressive Non-Hodgkin Lymphoma+10 more Fred Hutchinson Cancer Center 87
Early research (Phase 1)Study completedNCT00005064What this trial is testingPS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic SyndromeWho this might be right forAdult Acute Promyelocytic Leukemia (M3)Blastic Phase Chronic Myelogenous LeukemiaPreviously Treated Myelodysplastic Syndromes+5 more National Cancer Institute (NCI) 30